Acute toxicity study of Mesenchymal Stromal cells derived from Wharton’s Jelly in mouse by intravenous and subcutaneous route
Journal Title: International Journal of Research and Development in Pharmacy & Life Sciences (IJRDPL) - Year 2017, Vol 6, Issue 5
Abstract
Aim: The present study was to evaluate the acute toxicity of WJ-MSCs in mouse by intravenous and subcutaneous route and to assess their potential for side effects, MLD, MTD and LD50. Objectives: Wide ranges of clinical and preclinical trials have suggested exploitation of adult MSCs for the cell-based reparative therapeutic approach; considering pros and cons of embryonic stem cells. However, for the clinical use existing adult stem cells source such as bone marrow, adipose tissue may be detrimental due to invasiveness in the procedure, less number of initial isolation and unsuitability for allogenic transplants. Recently fetal tissues such as Placenta, WJ have attracted as a good stem cell source due to its easy accessibility, ethical safety, immunological tolerance and large number of initial isolation of homogenous population necessary for increasing current market demand. Methods: In present study, we tried to work on complete characterization and up-scaling profiling of cells isolated from WJ, along with assessment of possible toxic effects of these cells when administered in-vivo and optimizing the route of administration with other clinical evaluation been addressed. Results: We confirmed that cells isolated from WJ exhibit morphologically and phenotypically similar properties as MSCs. The animal study also reveled that no mortality, no abnormal clinical signs and no remarkable pathological changes. Conclusion: Our animal toxicity study along with attempted rapid expansion of these cells to meet large clinical demands would allow them to be a lucrative candidate for clinical therapy.
Authors and Affiliations
Jaianand Kannaiyan| Research and Development, CelluGen Biotech Private Limited, 62 Udyog Vihar, Phase 1, Gurugram, India, Suriya Narayanan| Research and Development, CelluGen Biotech Private Limited, 62 Udyog Vihar, Phase 1, Gurugram, India, Palaniyandi M| Research and Development, CelluGen Biotech Private Limited, 62 Udyog Vihar, Phase 1, Gurugram, India, Anubhav Pandey| Research and Development, CelluGen Biotech Private Limited, 62 Udyog Vihar, Phase 1, Gurugram, India
Keywords
Related Articles
- EP ID EP16035
- DOI http://dx.doi.org/10.21276/IJRDPL.2278-0238.2017.6(5).2748-2
- Views 322
- Downloads 18
Inhibition of Pro-Inflammatory Cytokine TNF-α by Boerhaavia diffusa (L.) in Liposaccharide stimulated Human THP-1 cells
The production and release of proinflammatory cytokines such as Tumor necrotic factor-α (TNF- α), Interleukin-1β and Iinterleukin-6 from monocytes/macrophages play critical role in the pathogenesis of chronic inflam...
Formulation and evaluation of Buccal patches of Furosemide
This study is mainly focused on the ability of polymer to increase the bioavailability of Furosemide and to release the drug in controlled predetermined manner. The polymers selected for the study include natural and s...
ASSOCIATION OF THE SHANK3 GENE COUPLED WITH 22Q13.3 DELETION SYNDROME
Phelan-McDermid syndrome (PMS) is a postnatal neurodegenerative disorder which is caused by the mutation in the gene called SHANK3, a member of the highly conserved Shank/ProSAP family of synaptic scaffolding proteins....
Formulation and evaluation of Tadalafil oral disintegrating tablets with enhanced dissolution rate by complexation
Aim: In the present study was to enhance the solubility of Tadalafil (TDF) by forming inclusion complexes with β-cyclodextrin (βCD) and further to enhance its dissolution rate by formulating orally disintegrating tab...
ENHANCEMENT OF TRANSDERMAL PERMEATION OF CARVEDILOL BY SONOPHORESIS TECHNIQUE: IN VITRO EVALUATION
In this study, various matrix type transdermal patches containing carvedilol of variable combination of polyvinylpyrrolidone (PVP) and ethylcellulose (EC) were prepared by solvent evaporation technique. The patches were...